TY - JOUR
KW - Type 2 diabetes
KW - bisoprolol
KW - dyslipidemia
KW - erectile dysfunction
KW - hypertension
KW - obesity
AU - C. Foch
AU - A. Allignol
AU - T. Hohenberger
AU - E. Boutmy
AU - S. Schaefer
AU - U. Hostalek
AD - Merck KGaA, Frankfurter Str 250, Darmstadt, 64293, Germany.
AN - 35189710
BT - J Comp Eff Res
DO - 10.2217/cer-2021-0305
DP - NLM
ET - 2022/02/23
LA - eng
N1 - 2042-6313
Foch, Caroline
Orcid: 0000-0002-0254-5560
Allignol, Arthur
Orcid: 0000-0002-2362-0072
Hohenberger, Thilo
Orcid: 0000-0002-0021-1401
Boutmy, Emmanuelle
Orcid: 0000-0001-9657-9376
Schaefer, Stephan
Orcid: 0000-0002-2720-2222
Hostalek, Ulrike
Orcid: 0000-0002-0770-4743
Merck KGaA/
Journal Article
England
J Comp Eff Res. 2022 Feb 22. doi: 10.2217/cer-2021-0305.
PY - 2022
SN - 2042-6305
T2 - J Comp Eff Res
TI - Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink
ER -